Intellia Therapeutics, Inc. (NTLA) NASDAQ
13.13
-0.6(-4.37%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
13.13
-0.6(-4.37%)
Currency In USD
| Market Cap | 974.3M |
| Enterprise Value | 912.17M |
| P/E Ratio | -3.94 |
| PEG Ratio | -0.09 |
| Price/Sales Ratio | 22.29 |
| Price/Book Ratio | 2.51 |
| Enterprise/Revenue | 21.47 |
| Enterprise/EBITDA | -3.57 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -5.97 |
| Operating Margin | -6.37 |
| Return On Assets | -0.52 |
| Return On Equity | -0.57 |
| Revenue | 67.67M |
| Revenue/Share | 0.56 |
| Gross Profit | 51.75M |
| EBITDA | -396.77M |
| Net Income | -412.69M |
| Diluted EPS | -3.81 |
| Total Cash | 375.99M |
| Total Cash/Share | 3.17 |
| Total Debt | 80.49M |
| Total Debt/Equity | 0.13 |
| Current Ratio | 6.1 |
| Book Value Per Share | 5.24 |
| 52-Week Change | 83.38 |
| 52-Week High | 28.25 |
| 52-Week Low | 6.98 |
| Moving Average 50 Days | 13.59 |
| Moving Average 200 Days | 13.29 |
| Average Volume | 5.53M |
| Shares Outstanding | 112.21M |
| % Held by Institutions | 101.88 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |